The upward trend should support Bayer in the coming sessions.

The company has interesting growth perspectives concerning revenues and earnings. For the current year, analysts expect 4% progression for turnover and around 25% for net result. Current valuation is a bit high but justified by the growth prospects.

Bayer is in bullish trend in the medium and long term. In weekly data, moving averages are well-oriented and support the stock upward progression. In the present configuration, the return on EUR 100 gives a pertinent buying area for investors. It could be interesting in the coming sessions with EUR 106.6 as target.

The decline observed in the short term offers an interesting entry point for a mid-term investment. Investors will take advantage of the current area to buy Bayer. The objectives will be set at EUR 103.25 and by extension EUR 106.6. The stop loss will be triggered below the EUR 99 support.